A detailed history of Gladstone Institutional Advisory LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 75,132 shares of MRK stock, worth $9.3 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
75,132
Previous 94,642 20.61%
Holding current value
$9.3 Million
Previous $10.3 Million 3.92%
% of portfolio
0.55%
Previous 0.58%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $2.21 Million - $2.57 Million
-19,510 Reduced 20.61%
75,132 $9.91 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $1.87 Million - $2.04 Million
18,679 Added 24.59%
94,642 $10.3 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $502,704 - $558,273
4,883 Added 6.87%
75,963 $7.82 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $1.38 Million - $1.5 Million
12,702 Added 21.76%
71,080 $8.2 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $3.98 Million - $4.44 Million
-38,699 Reduced 39.86%
58,378 $6.21 Million
Q4 2022

Feb 01, 2023

BUY
$87.44 - $112.11 $3.72 Million - $4.77 Million
42,544 Added 78.02%
97,077 $10.8 Million
Q3 2022

Jan 27, 2023

BUY
$84.53 - $94.96 $243,869 - $273,959
2,885 Added 5.59%
54,533 $4.7 Million
Q3 2022

Oct 20, 2022

BUY
$84.53 - $94.96 $243,869 - $273,959
2,885 Added 5.59%
54,533 $4.7 Million
Q2 2022

Jan 27, 2023

SELL
$83.49 - $94.64 $72,135 - $81,768
-864 Reduced 1.65%
51,648 $4.71 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $72,135 - $81,768
-864 Reduced 1.65%
51,648 $4.71 Million
Q1 2022

Jan 27, 2023

BUY
$73.51 - $82.4 $185,465 - $207,895
2,523 Added 5.05%
52,512 $4.31 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $185,465 - $207,895
2,523 Added 5.05%
52,512 $4.31 Million
Q4 2021

Jan 27, 2023

BUY
$72.28 - $90.54 $746,507 - $935,097
10,328 Added 26.04%
49,989 $3.83 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $746,507 - $935,097
10,328 Added 26.04%
49,989 $3.83 Million
Q3 2021

Jan 27, 2023

BUY
$71.68 - $78.83 $260,843 - $286,862
3,639 Added 10.1%
39,661 $2.98 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $260,843 - $286,862
3,639 Added 10.1%
39,661 $2.98 Million
Q2 2021

Jan 27, 2023

BUY
$70.31 - $77.77 $438,242 - $484,740
6,233 Added 20.92%
36,022 $2.8 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $438,242 - $484,740
6,233 Added 20.92%
36,022 $2.8 Million
Q1 2021

Jan 27, 2023

BUY
$68.86 - $81.11 $1.16 Million - $1.36 Million
16,805 Added 129.43%
29,789 $2.3 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $1.16 Million - $1.36 Million
16,805 Added 129.43%
29,789 $2.3 Million
Q4 2020

Jan 27, 2023

SELL
$71.77 - $79.65 $297,271 - $329,910
-4,142 Reduced 24.19%
12,984 $1.06 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $297,271 - $329,910
-4,142 Reduced 24.19%
12,984 $1.06 Million
Q3 2020

Jan 27, 2023

SELL
$73.18 - $82.95 $2.74 Million - $3.1 Million
-37,407 Reduced 68.6%
17,126 $1.42 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $293,598 - $332,795
4,012 Added 30.59%
17,126 $1.42 Million
Q2 2020

Aug 17, 2020

SELL
$70.42 - $80.13 $149,431 - $170,035
-2,122 Reduced 13.93%
13,114 $1.01 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $196,796 - $272,768
3,106 Added 25.61%
15,236 $1.17 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $110,551 - $124,744
1,425 Added 13.31%
12,130 $1.1 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $397,365 - $433,143
5,223 Added 95.28%
10,705 $901,000
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $135,699 - $158,529
1,943 Added 54.9%
5,482 $460,000
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $4,522 - $5,158
65 Added 1.87%
3,539 $294,000
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $226,643 - $263,016
3,474 New
3,474 $265,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.